Douglas Manion, M.D., FRCP (C), as President and COO
“We are excited to strengthen our leadership team by welcoming
“Aclaris is at an exciting stage in its life, and I am thrilled to join the organization,” said
Dr. Manion’s appointment is effective
Cautionary Note Regarding Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as “believe,” “expect,” “intend,” “may,” “plan,” “potential,” “will,” and similar expressions, and are based on Aclaris’ current beliefs and expectations. These forward-looking statements include the future contributions of
Source: Aclaris Therapeutics, Inc.